When comparing iNPH patients to AD patients, the majority of the studies agree with lower concentrations of t-tau and p-tau, whereas Aβ42 is either higher or similar/non-significantly different [36,37,38,39,41,42,45,48,54]. This evidence concerns the gene MAPT and Alzheimer disease.